Artiva Biotherapeutics, Inc. ARTV Personnel-Related — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses?
- Artiva Biotherapeutics, Inc. (ARTV) reported personnel-related — operating expenses of $10.35M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses changed year-over-year?
- Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses increased by 8.1% year-over-year, from $9.57M to $10.35M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s personnel-related — operating expenses has grown at a 17.2% compound annual growth rate (CAGR), from $28.61M to $39.29M.
- What does personnel-related — operating expenses mean?
- This metric represents the total operating expenditures directly attributable to employee compensation, benefits, and related human capital costs within the organization. It serves as a key indicator of the company's investment in its workforce to support research, development, and administrative functions. Monitoring this figure helps investors assess the scalability of the company's operational model and the efficiency of its human resource allocation relative to its clinical pipeline progress.